ArticleAnnals of hematology2025

Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in newly diagnosed and relapsed/refractory acute myeloid leukemia: results of a single center study.

Ting Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.